Table 2.
Proportion of metabolic syndrome according to three different criteria.
Criteria | Definition factors | Metabolic syndrome definition | Gastric Cancer (n*, %) | Control (n*, %) | x2 | P |
---|---|---|---|---|---|---|
Total | 808 | 1,146 | ||||
NCEPATP III (Asian) | WC | >90cm for male, >80cm for female | 185 (22.8) | 210 (18.3) | 6.140 | 0.014 |
TG | ≥1.70 mmol/L | 152 (18.8) | 203 (17.7) | 0.384 | 0.552 | |
HDL-C | < 1.0 mmol/L for male, < 1.3 for female | 241 (29.8) | 161 (10.6) | 72.194 | < 0.001 | |
Hypertension | Systolic BP ≥ 130, diastolic BP ≥ 85 mmHg or hypertension history | 301 (37.2) | 332 (29.0) | 14.842 | < 0.001 | |
Fasting blood glucose | ≥ 6.1 mmol/L or diabetes history | 188 (23.3) | 162 (14.1) | 26.872 | < 0.001 | |
MetS | Criteria 3 or more of the above | 164 (20.3) | 152 (13.3) | 17.293 | < 0.001 | |
IDF (Chinese) | WC | >90cm for male, >80cm for female | 185 (22.8) | 210 (18.3) | 6.140 | 0.014 |
TG | ≥1.70 mmol/L | 152 (18.8) | 203 (17.7) | 0.384 | 0.552 | |
HDL-C | < 1.0 mmol/L for male, < 1.3 for female | 241 (29.8) | 161 (10.6) | 72.194 | < 0.001 | |
Hypertension | Systolic BP ≥ 130, diastolic BP ≥ 85 mmHg or hypertension history | 301 (37.2) | 332 (29.0) | 14.842 | < 0.001 | |
Fasting blood glucose | ≥5.6 mmol/L or diabetes history | 212 (26.6) | 223 (19.5) | 12.282 | < 0.001 | |
MetS | WC necessary and any 2 or the above | 202 (25.0) | 189 (16.5) | 21.430 | < 0.001 | |
CDS | BMI | ≥ 25.0 kg/m2 | 242 (30.3) | 312 (27.2) | 2.230 | 0.140 |
TG | ≥1.70 mmol/L | 152 (18.8) | 203 (17.7) | 0.384 | 0.552 | |
HDL-C | < 0.9 mmol/L for male, < 1.0 for female | 134 (16.6) | 115 (10.0) | 18.280 | < 0.001 | |
Hypertension | Systolic BP ≥ 140, diastolic BP ≥ 90 mmHg or hypertension history | 212 (26.2) | 165 (14.4) | 42.661 | < 0.001 | |
Fasting blood glucose | ≥6.1 mmol/L or diabetes history | 188 (23.3) | 162 (14.1) | 26.872 | < 0.001 | |
MetS | Criteria 3 or more of the above | 154 (19.1) | 110 (9.6) | 32.510 | < 0.001 |
, n was positive patients number.
NECP, national cholesterol education program.
ATP-III, adult treatment panel-III.
IDF, International diabetes federation.
CDS, Chinese diabetes society.